ArticleScientific reports2024

PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy.

Mariam Ben Kacem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.